Cell study: CBD protected nerve cells in Parkinson’s model

A new bioRxiv preprint describes how cannabidiol, CBD, protected dopamine-like nerve cells from oxidative stress in a laboratory model of Parkinson’s disease. The study has not yet been peer reviewed and the findings apply to cell models, not patients.

CBD was tested against oxidative stress in a Parkinson’s model

Parkinson’s disease is characterized in part by the gradual loss of dopaminergic nerve cells and damage linked to oxidative stress. The researchers used SH-SY5Y cells, a common cell model in neuroscience, and exposed them to 6-hydroxydopamine, 6-OHDA, a compound used to mimic damage similar to that seen in Parkinson’s disease.

CBD was first tested at different concentrations to identify a level that did not itself harm the cells. The researchers then selected 5 micromolar CBD as the main dose in the experiments. At this level, CBD reduced cell damage after exposure to 6-OHDA and also showed protective effects against other Parkinson-related toxins in the model.

Nrf2 may be central to CBD’s protective effect

The study focuses particularly on Nrf2, a transcription factor that helps cells activate antioxidant defenses. Under severe oxidative stress, the researchers report that Nrf2 can become trapped in insoluble accumulations in the cell cytoplasm, which may weaken the cell’s ability to handle harmful reactive oxygen species.

The researchers report that CBD helped keep Nrf2 in a more soluble and functional form. This was linked to increased phosphorylation of Nrf2, restored transport into the cell nucleus and stronger activation of antioxidant genes such as HMOX1 and NQO1.

CBD reduced ROS and protected mitochondria

When the cells were exposed to 6-OHDA, levels of reactive oxygen species, ROS, increased. CBD treatment before the toxin reduced this oxidative burden and kept levels closer to the control group. The effect was seen both in undifferentiated cells and in more neuron-like, differentiated SH-SY5Y cells.

The study also showed that CBD helped preserve mitochondrial structure. 6-OHDA led to fragmented and irregular mitochondria, while cells pretreated with CBD more often retained a more normal network. The researchers also reported that CBD reduced excessive mitophagy, the breakdown of damaged mitochondria.

The findings are preclinical and require caution

The results point to a possible mechanism in which CBD does not only act as a general antioxidant, but also affects the cell’s own defense system through Nrf2. This makes the study relevant for continued research on cannabinoids and neurodegenerative diseases.

At the same time, the results should not be interpreted as evidence of a treatment effect in people with Parkinson’s disease. The study is a preprint, is based on cell models and needs to be followed by further preclinical and clinical studies before any conclusions can be drawn about medical use.

Source

Cannabidiol confers neuroprotection against 6-OHDA toxicity by rescuing Nrf2 proteostasis and preserving mitochondrial integrity